DMK Pharmaceuticals Corporation 0A4X.L Stock
DMK Pharmaceuticals Corporation Price Chart
DMK Pharmaceuticals Corporation 0A4X.L Financial and Trading Overview
| DMK Pharmaceuticals Corporation stock price | 0.05 USD |
| Previous Close | 1.96 USD |
| Open | 0 USD |
| Bid | 0 USD x N/A |
| Ask | 0 USD x N/A |
| Day's Range | 0 - 0 USD |
| 52 Week Range | 0 - 35.71 USD |
| Volume | 11.12K USD |
| Avg. Volume | 151 USD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 1.227464 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.273 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0A4X.L Valuation Measures
| Enterprise Value | 2.54M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.503 |
| Enterprise Value/EBITDA | -0.114 |
Trading Information
DMK Pharmaceuticals Corporation Stock Price History
| Beta (5Y Monthly) | 1.227464 |
| 52-Week Change | -92.47% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 35.71 USD |
| 52 Week Low | 0 USD |
| 50-Day Moving Average | 9.79 USD |
| 200-Day Moving Average | 13.42 USD |
0A4X.L Share Statistics
| Avg. Volume (3 month) | 151 USD |
| Avg. Daily Volume (10-Days) | 276 USD |
| Shares Outstanding | N/A |
| Float | 2.1M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 0.014286:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -466.37% |
| Gross Margin | -28.83% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -74.36% |
| Return on Equity (ttm) | -784.96% |
Income Statement
| Revenue (ttm) | 5.05M USD |
| Revenue Per Share (ttm) | 2.35 USD |
| Quarterly Revenue Growth (yoy) | 25.90% |
| Gross Profit (ttm) | -1431408 USD |
| EBITDA | -22324544 USD |
| Net Income Avi to Common (ttm) | -25024260 USD |
| Diluted EPS (ttm) | -0.273 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.1M USD |
| Total Cash Per Share (mrq) | 1.25 USD |
| Total Debt (mrq) | 380.51K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.583 |
| Book Value Per Share (mrq) | -4.071 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -20470072 USD |
| Levered Free Cash Flow (ttm) | -7864601 USD |
Profile of DMK Pharmaceuticals Corporation
| Country | United Kingdom |
| State | CA |
| City | San Diego |
| Address | 11682 El Camino Real |
| ZIP | 92130 |
| Phone | 858 997 2400 |
| Website | https://www.adamispharmaceuticals.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 11 |
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease. Its products include SYMJEPI epinephrine injectable pre-filled single dose syringe products for use in the emergency treatment of acute allergic reactions comprising anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company was founded in 2006 and is headquartered in San Diego, California.
Q&A For DMK Pharmaceuticals Corporation Stock
What is a current 0A4X.L stock price?
DMK Pharmaceuticals Corporation 0A4X.L stock price today per share is 0.05 USD.
How to purchase DMK Pharmaceuticals Corporation stock?
You can buy 0A4X.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for DMK Pharmaceuticals Corporation?
The stock symbol or ticker of DMK Pharmaceuticals Corporation is 0A4X.L.
How many shares does DMK Pharmaceuticals Corporation have in circulation?
The max supply of DMK Pharmaceuticals Corporation shares is 0.
What is DMK Pharmaceuticals Corporation Price to Earnings Ratio (PE Ratio)?
DMK Pharmaceuticals Corporation PE Ratio is now.
What was DMK Pharmaceuticals Corporation earnings per share over the trailing 12 months (TTM)?
DMK Pharmaceuticals Corporation EPS is -0.273 USD over the trailing 12 months.